News
20hon MSN
GLP-1 drugs such as Lilly’s Mounjaro and Novo’s Ozempic linked to lower cancer risk: study
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
With the price of weight-loss injection Mounjaro rising by 170 per cent next month, we asked a pharmacist and medical ...
Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how ...
In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...
GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...
A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...
Tennis legend Serena Williams has sparked conversations around fitness and health after reports of her weight loss journey ...
Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...
The mother-of-two was seen in a snakeskin print push-up bra dress by L'Agence as she stopped by the Today show to talk her ...
GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...
8h
Health and Me on MSNSerena Williams Opens Up About Losing 31 lbs With GLP-1 Medication; Is This Breaking Stigma Or Joining The Trend?
Serena Williams revealed she lost 31 pounds using GLP-1 weight-loss drugs over the course of one year, sparking conversations ...
16h
21Ninety on MSNSerena Williams Opens Up About GLP-1 Weight Loss, Here’s What Women Should Know
Tennis legend Serena Williams has revealed that she’s lost 31 pounds over the last eight months using a GLP-1 medication.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results